Nazara Technologies' subsidiary Nodwin shareholding falls, Dixon's agreements with Chinese firms scrutinised, LT Foods opens ...

Lala Kent is sharing an update on her health after her doctor found a precancerous abnormality near her eye. Read on for more ...

Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5%, a generic equivalent to Lotemax, for eye inflammation treatment.

Lupin today announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United States. Loteprednol Etabonate Ophthalmic Suspension, 0.5% is bioequivalent to Lotemax Ophthalmic ...

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United ...

Lupin launches generic Loteprednol Etabonate Ophthalmic Suspension in the US market, a bioequivalent to Lotemax, to treat eye ...

Lupin has launched a generic eye medication in the US, aimed at treating inflammation and pain. This new product is a generic ...

Lupin introduces loteprednol etabonate ophthalmic suspension, 0.5% in US: Our Bureau, Mumbai Wednesday, July 16, 2025, 16:20 Hrs [IST] Global pharma major Lupin Limited (Lupin) an ...

Lupin announced that it has launched Loteprednol Etabonate Ophthalmic Suspension in the United States.

Loteprednol etabonate ophthalmic gel, 0.38%, is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery.

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...